Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-14

Clinical Trial Update: A Targeted Amino Acid Supplement for People With Parkinson's Disease [EARLY_Phase 1]

View source ↗

Summary

The document describes an early Phase 1 trial evaluating a targeted amino acid supplement for people with Parkinson's disease. The study is currently active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Targeted amino acid supplement

Snippet

Sponsor: UConn Health | Conditions: Parkinson Disease, Idiopathic | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING